NetworkNewsBreaks – CytoDyn Inc. (CYDY) President and CEO Featured in Uptick Newswire’s Stock Day Podcast

Biotechnology company CytoDyn (OTCQB: CYDY) this morning announced the featured interview of its President and CEO Nader Z. Pourhassan, Ph.D. with Stock Day’s Everett Jolly. Jolly initiated the discussion by asking about CytoDyn’s PRO 140. The company’s flagship product is a humanized IgG4 monoclonal antibody that is designed to bind to cellular receptor CCR5, which plays various roles with implications in HIV, tumor metastasis and immune signaling. Pending FDA approval, which the company hopes to secure in Q4 2019, Pourhassan indicates that PRO 140 may be available to the public in 2020.  “Most biotech companies, when they finish the biologic application, they have an 85% chance to get approved. 9 out of 10 who don’t get approved is because of the safety of the product. Our product has received fast track designation due to having great safety among all of the approved drugs,” Nader Z. Pourhassan, Ph.D., president and CEO of CytoDyn, stated in the news release.

To hear the Stock Day Podcast featuring the interview, visit http://nnw.fm/kYJU8

To view the full press release, visit http://nnw.fm/4Q7xo

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Launches Comprehensive POS Solution, Aptito NetworkNewsBreaks – Foresight Autonomous Holdings Ltd.’s (NASDAQ: FRSX) (TASE: FRSX) QuadSight Wins 2019 CES Innovation Award NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) Brings to Market its Cranberry & Shortbread Gummies: 2018 Holiday Limited Edition

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

Other Press Releases

The Latest: Trump thanks Saudi Arabia for lower oil prices

Nov 22, 2018

WASHINGTON — The Latest on the fallout from the killing of Saudi journalist Jamal Khashoggi (all times local): 8:45 a.m. President Donald Trump is thanking Saudi Arabia for plunging oil prices amid criticism over his decision not to further punish the kingdom for the killing of journalist Jamal Khashoggi (jah-MAHL' khahr-SHOHK'-jee). Trump tweeted Wednesday from his Mar-a-Lago club in Florida it's "Great!" oil prices are getting lower and it's "Like a big Tax Cut for America and the World." The international crude benchmark has fallen under $65 per barrel from a four-year high of more than $86 in October as...

Ludwig Goransson is having the best year ever. Period.

Nov 22, 2018

NEW YORK — Though he's virtually unknown to the larger public, Ludwig Goransson had one of the best years in entertainment. The 34-year-old was part of two of the biggest pop culture moments in 2018 with the success of "Black Panther," for which he composed the score, and Childish Gambino's hit "This Is America," produced and co-written by Goransson. The Swedish musician will close the year on another high with Wednesday's release of "Creed II," which he scored. Goransson says "it definitely feels like I'm living a dream. But I try not to pinch myself because I don't want to...

Joanna Gaines tells how to make a house a home in new book

Nov 22, 2018

NEW YORK — Joanna Gaines, known for her cozy-yet-cool designs including open-concept floor plans, farmhouse sinks and sliding barn doors, admits having to scale back on the vision of her own home in Waco, Texas, to allow her children to add personality to their own spaces. "In the past it was hard," she said recently in an interview, having to shift her thinking to, "This is their space. This is what makes them come alive, I need to encourage that." Gaines says this principle especially applies to her two oldest children, son Drake, 13, and daughter Ella, 11. "In the...

Scorsese feted at MoMA by friends De Niro, DiCaprio, Hill

Nov 22, 2018

NEW YORK — Many young boys grow up with superheroes adorning their walls. Jonah Hill grew up with a picture of Martin Scorsese on his. The actor related the poignant anecdote at a star-studded benefit Monday evening at the Museum of Modern Art, honoring the celebrated director both for his contributions to both cinema and to film restoration and preservation. "You might not even understand how often just the image of you creates young people who want to be filmmakers every single day," said Hill, who worked with Scorsese on "The Wolf of Wall Street" and just released his directorial...

White House again threatens Acosta's pass; CNN seeks hearing

Nov 22, 2018

WASHINGTON — The Trump administration has again targeted White House press credentials for CNN reporter Jim Acosta. After a federal judge ordered that Acosta's credentials be temporarily restored last week, the White House sent Acosta a letter saying it had made the "preliminary decision" to suspend his pass. The White House said Acosta would continue to hold his credentials while the 14-day judge's order was in effect. The White House argues Acosta did not follow "basic standards" when he scrapped with President Donald Trump at a news conference. The letter from Press Secretary Sarah Huckabee Sanders and Communications Director Bill...

Hollywood in five is your 5 minutes read of Hollywood news with continual updated coverage.

Contact us: sales@hollywoodinfive.com